Immatics and Editas join up to bring CRISPR to ‘gamma delta’ cell therapy
June 7, 2022Sanofi moves into big Cambridge HQ, where 2,500 will work
June 7, 2022Mirati Therapeutics presented the first clinical data demonstrating CNS-specific activity of a KRASG12C inhibitor in patients with NSCLC with active and untreated CNS metastases.
